NL145553B - Werkwijze ter bereiding van imidazolylcarbaminezuurderivaten, werkwijze ter bereiding van anthelmintisch werkzame preparaten en gevormde preparaten. - Google Patents
Werkwijze ter bereiding van imidazolylcarbaminezuurderivaten, werkwijze ter bereiding van anthelmintisch werkzame preparaten en gevormde preparaten.Info
- Publication number
- NL145553B NL145553B NL717112971A NL7112971A NL145553B NL 145553 B NL145553 B NL 145553B NL 717112971 A NL717112971 A NL 717112971A NL 7112971 A NL7112971 A NL 7112971A NL 145553 B NL145553 B NL 145553B
- Authority
- NL
- Netherlands
- Prior art keywords
- preparing
- preparations
- imidazolylcarbamic
- acid derivatives
- anthelmintic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7034133A FR2105060A1 (en) | 1970-09-21 | 1970-09-21 | Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use |
| FR7130825A FR2150236A2 (en) | 1971-08-25 | 1971-08-25 | Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL7112971A NL7112971A (xx) | 1972-03-23 |
| NL145553B true NL145553B (nl) | 1975-04-15 |
Family
ID=26215952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL717112971A NL145553B (nl) | 1970-09-21 | 1971-09-21 | Werkwijze ter bereiding van imidazolylcarbaminezuurderivaten, werkwijze ter bereiding van anthelmintisch werkzame preparaten en gevormde preparaten. |
Country Status (13)
| Country | Link |
|---|---|
| AU (1) | AU453067B2 (xx) |
| BE (1) | BE772835A (xx) |
| CA (1) | CA940131A (xx) |
| CH (1) | CH532600A (xx) |
| DE (1) | DE2147103C3 (xx) |
| DK (1) | DK131345B (xx) |
| ES (2) | ES395260A1 (xx) |
| GB (1) | GB1318859A (xx) |
| HU (1) | HU163150B (xx) |
| IL (1) | IL37752A (xx) |
| LU (1) | LU63927A1 (xx) |
| NL (1) | NL145553B (xx) |
| SE (1) | SE368828B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60021065T2 (de) | 1999-03-31 | 2006-06-01 | UAF Technologies and Research, LLC, Tucson | Virus behandlung |
| US6593466B1 (en) | 1999-07-07 | 2003-07-15 | Isis Pharmaceuticals, Inc. | Guanidinium functionalized nucleotides and precursors thereof |
| US6384049B1 (en) * | 2000-05-25 | 2002-05-07 | The Procter & Gamble Company | Cancer treatment |
-
1971
- 1971-09-17 IL IL37752A patent/IL37752A/en unknown
- 1971-09-20 HU HURO628A patent/HU163150B/hu unknown
- 1971-09-20 LU LU63927D patent/LU63927A1/xx unknown
- 1971-09-20 DK DK458771AA patent/DK131345B/da unknown
- 1971-09-20 BE BE772835A patent/BE772835A/xx unknown
- 1971-09-20 CH CH1372371A patent/CH532600A/fr not_active IP Right Cessation
- 1971-09-20 SE SE11891/71A patent/SE368828B/xx unknown
- 1971-09-20 CA CA123264A patent/CA940131A/en not_active Expired
- 1971-09-21 DE DE2147103A patent/DE2147103C3/de not_active Expired
- 1971-09-21 ES ES395260A patent/ES395260A1/es not_active Expired
- 1971-09-21 GB GB4400371A patent/GB1318859A/en not_active Expired
- 1971-09-21 NL NL717112971A patent/NL145553B/xx unknown
- 1971-09-21 AU AU33735/71A patent/AU453067B2/en not_active Expired
-
1972
- 1972-06-15 ES ES403910A patent/ES403910A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES395260A1 (es) | 1973-12-01 |
| LU63927A1 (xx) | 1972-06-27 |
| AU453067B2 (en) | 1974-09-19 |
| IL37752A0 (en) | 1971-11-29 |
| IL37752A (en) | 1974-10-22 |
| DK131345B (da) | 1975-06-30 |
| DK131345C (xx) | 1975-11-24 |
| SE368828B (xx) | 1974-07-22 |
| GB1318859A (en) | 1973-05-31 |
| CH532600A (fr) | 1973-01-15 |
| HU163150B (xx) | 1973-06-28 |
| DE2147103B2 (de) | 1974-11-14 |
| NL7112971A (xx) | 1972-03-23 |
| CA940131A (en) | 1974-01-15 |
| ES403910A1 (es) | 1975-05-01 |
| BE772835A (fr) | 1972-03-20 |
| AU3373571A (en) | 1973-03-29 |
| DE2147103C3 (de) | 1975-07-17 |
| DE2147103A1 (de) | 1972-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL174943C (nl) | Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van een 8-azapurin-6-onderivaat. | |
| NL147139B (nl) | Werkwijze ter bereiding van n-benzimidazolylcarbamaten, alsmede van anthelmintisch werkzame preparaten en aldus verkregen preparaten, die deze verbindingen bevatten. | |
| NL7502450A (nl) | Werkwijze voor het bereiden van werkzame cyclo- hexanolderivaten en van preparaten, die deze bevatten. | |
| NL174547C (nl) | Werkwijze ter bereiding van benzoylpropionzuurderivaten, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten. | |
| NL157006B (nl) | Werkwijze voor het bereiden van anti-inflammatoir werkzame fenoxyfenylazijnzuurderivaten en farmaceutisch preparaat, dat deze verbinding bevat. | |
| NL168210C (nl) | Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van cyclische carbonzuurderivaten. | |
| NL139959B (nl) | Werkwijze ter bereiding van anti-inflammatoir werkzame naftylazijnzuurderivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten. | |
| NL170284C (nl) | Werkwijze ter bereiding van 1.2.3.5.6.12.13.13a-octahydro 12 oxoindolo 3.2.1-d.epyrido 3.2.1-i.jnaftyridinen, alsmede werkwijze ter bereiding van farmaceutische preparaten. | |
| NL172240C (nl) | Werkwijze om pteridinederivaten te bereiden en farmaceutische preparaten, welke deze verbindingen bevatten. | |
| NL175724C (nl) | Werkwijze ter bereiding van 1-fenylvinyl-1-fosfonzuur. | |
| NL174798C (nl) | Werkwijze ter bereiding van acaricide preparaten. | |
| NL148317B (nl) | Werkwijze voor de bereiding van benzo (b) thiofeenazijnzuurderivaten, en van preparaten die ze bevatten. | |
| FI49504C (fi) | Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi. | |
| NL149812B (nl) | Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat. | |
| NL145553B (nl) | Werkwijze ter bereiding van imidazolylcarbaminezuurderivaten, werkwijze ter bereiding van anthelmintisch werkzame preparaten en gevormde preparaten. | |
| NL169462C (nl) | Werkwijze ter bereiding van 1-(3-trifluormethylfenyl)-2-aminopropaan-derivaten en van farmaceutische preparaten, die de genoemde derivaten als actief bestanddeel bevatten. | |
| NL155542B (nl) | Werkwijze ter bereiding van hydantoinederivaten en fungicide preparaten die deze derivaten bevatten. | |
| NL170852C (nl) | Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van anti-inflammatoir werkzaam p-isoindolinylfenylazijnzuur en van derivaten hiervan. | |
| NL7409840A (nl) | Werkwijze ter bereiding van thienopyridinecar- bonzuurderivaten, alsmede werkwijze ter berei- ding van farmaceutische preparaten die deze derivaten bevatten. | |
| NL142670B (nl) | Werkwijze ter bereiding van 19-norsteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten. | |
| NL142332B (nl) | Werkwijze ter bereiding van psychostimulerend werkzame zouten van met een dicarbonzuurderivaat veresterde pyridoxolmonoesters en deze verbindingen bevattende preparaten, alsmede aldus verkregen gevormde preparaten. | |
| NL149082B (nl) | Werkwijze ter bereiding van farmaceutische preparaten, gevormde preparaten en werkwijze ter bereiding van daarvoor geschikte thiazolino (3,2-a)-5-pyrimidinonderivaten. | |
| NL152930B (nl) | Werkwijze voor het bereiden van citroenzuur. | |
| NL152601B (nl) | Werkwijze ter bereiding van citroenzuur. | |
| NL7512585A (nl) | Werkwijze ter bereiding van prostaanzuurderivaten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VJC | Lapsed due to non-payment of the due maintenance fee for the patent or patent application |